These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35347593)

  • 1. Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge.
    Vater LB; Lefebvre B; Turk A; Clasen SC
    Curr Oncol Rep; 2022 Jul; 24(7):943-950. PubMed ID: 35347593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
    Kelly C; Bhuva N; Harrison M; Buckley A; Saunders M
    Eur J Cancer; 2013 Jul; 49(10):2303-10. PubMed ID: 23583220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
    Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
    ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rechallenge capecitabine after fluoropyrimidine-induced cardiotoxicity in rectal cancer: A case report.
    Peng T; Ouyang Y; Tong K
    Medicine (Baltimore); 2019 Jan; 98(2):e14057. PubMed ID: 30633206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
    Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
    BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
    Saneeymehri SS; Markey KR; Mahipal A
    J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoropyrimidine-associated cardiotoxicity: revisited.
    Saif MW; Shah MM; Shah AR
    Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.
    Saif MW
    Onco Targets Ther; 2020; 13():10197-10206. PubMed ID: 33116601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
    Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
    Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
    Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
    Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.
    Clasen SC; Ky B; O'Quinn R; Giantonio B; Teitelbaum U; Carver JR
    J Gastrointest Oncol; 2017 Dec; 8(6):970-979. PubMed ID: 29299356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil and cardiotoxicity: a review.
    Sara JD; Kaur J; Khodadadi R; Rehman M; Lobo R; Chakrabarti S; Herrmann J; Lerman A; Grothey A
    Ther Adv Med Oncol; 2018; 10():1758835918780140. PubMed ID: 29977352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
    Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
    Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator.
    Abiodun A; Shawe-Taylor M; Tyebally S; Bagkeris E; Bajomo O; Artico J; Slater S; Raisi-Estabragh Z; Diamantis N; Manisty C
    ESC Heart Fail; 2024 Oct; 11(5):3041-3051. PubMed ID: 38845140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil Rechallenge After Cardiotoxicity.
    Desai A; Mohammed T; Patel KN; Almnajam M; Kim AS
    Am J Case Rep; 2020 Aug; 21():e924446. PubMed ID: 32860674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death.
    More LA; Lane S; Asnani A
    Curr Cardiol Rep; 2021 Feb; 23(3):17. PubMed ID: 33537861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine Versus Continuous Infusion Fluorouracil for the Treatment of Advanced or Metastatic Colorectal Cancer: a Meta-analysis.
    Wu Z; Deng Y
    Curr Treat Options Oncol; 2018 Nov; 19(12):77. PubMed ID: 30483908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.